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Abstract
Candidaemia is a bloodstream infection caused by Candida species that primarily affects
specific groups of at-risk patients. Because only small candidaemia patient cohorts are avail-
able, classical genome wide association cannot be used to identify Candida susceptibility
genes. Therefore, we have applied an integrative genomics approach to identify novel sus-
ceptibility genes and pathways for candidaemia. Candida-induced transcriptome changes in
human primary leukocytes were assessed by RNA sequencing. Genetic susceptibility to can-
didaemia was assessed using the Illumina immunochip platform for genotyping of a cohort
of 217 patients. We then integrated genetics data with gene-expression profiles, Candida-
induced cytokine production capacity, and circulating concentrations of cytokines. Based on
the intersection of transcriptome pathways and genomic data, we prioritized 31 candidate
genes for candidaemia susceptibility. This group of genes was enriched with genes involved
in inflammation, innate immunity, complement, and hemostasis. We then validated the role of
MAP3K8 in cytokine regulation in response to Candida stimulation. Here, we present a new
framework for the identification of susceptibility genes for infectious diseases that uses an
unbiased, hypothesis-free, systems genetics approach. By applying this approach to candi-
daemia, we identified novel susceptibility genes and pathways for candidaemia, and future
studies should assess their potential as therapeutic targets.
Introduction
Genome-wide association studies (GWAS) have greatly contributed to the identification
of susceptibility genes for human complex diseases. However, the need for large cohorts
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precludes the use of GWAS to identify susceptibility genes for infectious diseases for which
only relatively small patient cohorts can be recruited. So far, relatively few GWAS studies have
been performed in patients with infections, including studies of viral and bacterial infections
[1]. Compared to the hundreds of genetic loci that have been associated to human complex
diseases, the number of susceptibility genes identified as associated to infectious diseases
remains low. Given that the risk of death due to infectious diseases has a large genetic heritabil-
ity [2], methods other than GWAS that can be applied to smaller cohorts are crucial to make
progress in understanding and treating these diseases.
Candidaemia is the fourth most common systemic bloodstream infection in the United
States (US) and is associated with mortality rates of up to 40% [3,4]. It is caused by opportunis-
tic fungal pathogens belonging to the Candida species, particularly Candida albicans (C. albi-
cans), and primarily affects patients with a compromised immune system [5]. However, not all
at-risk patients develop candidaemia, indicating that individual differences—including genetic
background—influence their susceptibility to the infection. Despite the availability of potent
antifungal drugs, the mortality rate of systemic Candida infections remains unacceptably high
[6]. In addition to current treatment strategies, only adjuvant immunotherapy such as the
administration of recombinant cytokines is believed to improve outcome [7]. Therefore, an
understanding of the molecular pathways involved in the human host defence and identifica-
tion of susceptibility genes is crucial for the design of appropriate prophylactic and immuno-
therapeutic strategies.
To identify genes underlying susceptibility to Candida infection, we have applied a systems
genomics approach that integrates genetic data from candidaemia patients genotyped with the
Immunochip platform [8] with Candida-induced gene-expression profiles in human leukocytes,
cytokine production from Candida-stimulated peripheral blood mononuclear cells (PBMCs),
and circulating cytokine concentrations in candidaemia patients. Using this approach, we dem-
onstrate that genetic susceptibility loci with suggestive associations (P< 9.99 x 10−5) could play
a major role in candidaemia susceptibility and we identify genes involved in inflammation,
innate immunity, complement and hemostasis as having an important role in determining sus-
ceptibility to candidaemia.
Materials and methods
Study populations
To identify genetic variants associated with candidaemia, we performed a two-stage Immu-
nochip-wide analysis of a candidaemia cohort using two control groups in 2014: a popula-
tion-based healthy cohort and disease-matched cohort (European ancestry), as previously
described [9]. Briefly, for Immunochip-wide association analysis, we first used a cohort
consisting of 217 candidaemia patients of European ancestry and 11,920 population-based
healthy controls (Discovery stage). The demographic and clinical characteristics of the can-
didaemia cohort have been previously described [9]. Re-analysis of the data and prioritiza-
tion of genes from susceptibility loci with suggestive associations (P < 9.99 x 10−5) was
performed in 2017.
After the discovery of single nucleotide polymorphisms (SNPs) for susceptibility to can-
didaemia using population-based healthy controls, we then validated our findings using a
validation control consisting of 146 disease-matched but candidiasis-free controls. These
candidiasis-free control patients were recruited from the same hospital wards as the candi-
daemia patients so that co-morbidities and clinical risk factors for infection were as similar
as possible between patients and controls.
Integrative genomics approach and candidaemia susceptibility pathways
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Ethics statement
The study was approved by the institutional review boards at each study centre, and enroll-
ment occurred between January 2003 and January 2009. The study centers are the Duke Uni-
versity Hospital (DUMC, Durham, North Carolina, USA) and Radboud University Nijmegen
Medical Centre (Nijmegen, The Netherlands). All adult subjects provided informed written
consent.
Genotyping and case-control analysis of candidaemia cohort
DNA was isolated using the Gentra Pure Gene Blood kit (Qiagen, Venlo, the Netherlands)
according to the protocol of the manufacturer. Genotyping of candidaemia patients and both
control groups was performed using Immunochip according to Illumina’s protocol [10].
Genotype data analysis and quality control of this cohort has been previously reported [9].
Briefly, in the discovery stage, the associations of Immunochip SNPs and susceptibility with
candidaemia were tested by logistic regression using the first four components from the multi-
dimensional scaling analysis as covariates. We considered a P value< 9.99 x 10−5 as the thresh-
old for suggestive association to select 268 SNPs in 77 independent loci for validation. For
validation analysis using candidaemia case-matched controls, the association between SNPs
and candidaemia was tested by logistic regression using the first four multidimensional scaling
analysis components as covariates. A validation P value < 0.05 was considered significant.
PBMC isolation and stimulation with Candida albicans
Isolation of PBMCs from eight healthy volunteers and stimulation of PBMCs was performed
as described previously [11]. After cell counting with a hemocytometer, the cell number was
adjusted to 5 x 106/mL. To identify the transcriptome upon Candida stimulation, 5 x 105 iso-
lated PBMCs were incubated with 1 x 106/mL heat-killed C. albicans (UC 820) (C. albicans:
PBMC ratio of 1:2.5) and RPMI culture medium as a control for 4 and 24 hours. C. albicans
UC 820 is a well-described strain regarding its immune responses in PBMCs [12].
Analysis of RNA sequencing reads
The RNA sequencing analysis of this dataset was described previously [13]. Briefly, sequencing
reads were mapped to the human genome using STAR (version 2.3.0). The aligner was provided
with a file containing junctions from Ensembl GRCh37.71. The Htseq-count of the Python pack-
age HTSeq (version 0.5.4p3) was used (http://www-huber.embl.de/users/anders/HTSeq/doc/
overview.html) to quantify the read counts per gene based on annotation version GRCh37.71,
using the default union-counting mode. Differentially expressed genes were identified by statisti-
cal analysis using the DESeq2 package. The statistically significant threshold (False Discovery
Rate P< 0.05 and Fold Change 2) was applied.
Pathway enrichment analysis
We performed gene enrichment analysis using ConsensusPathDB-human database (CPDB;
http://cpdb.molgen.mpg.de/) [14]. The over-representation analysis is done using the default
setting in which the database compares the predefined lists of functionally associated genes
(pathways and Gene Ontology categories) to the list of differentially expressed genes and gen-
erates P values based on the hypergeometric test. The hypergeometric test P values are further
corrected for multiple testing using the false discovery rate method.
Integrative genomics approach and candidaemia susceptibility pathways
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MAP3K8 inhibition of cytokines in Candida-stimulated PBMCs
PBMCs (5 x 105) were placed in 96-well round-bottom plates in a final volume of 200μL.
PBMCs were stimulated with (1 x 106/mL) heat-inactivated conidia of C. albicans in the pres-
ence or absence of variable concentrations (10μM, 50μM, and 200μM) of a MAP3K8 inhibitor
(#5240, Tocris Cookson Ltd., Bristol, UK) or a vehicle (DMSO) control. PBMCs were stimu-
lated for 24 or 48 hours at 37˚C and 5% CO2. After stimulation, culture supernatants were
collected and stored at -20˚C until cytokine assays were performed. Cytokine levels from Can-
dida-stimulated PBMCs were measured in cell culture supernatants using enzyme-linked
immunosorbent assay (ELISA) according to the manufacturer’s instructions (R&D Systems,
MN, USA). Differences in cytokine levels were compared for statistical significance using the
Wilcoxon rank test.
Results
Candida albicans induces transcription of genes involved in inflammation
and immune-hemostasis interaction
In our experiments, we have used heat-killed C. albicans instead of live C. albicans for two main
reasons. The first one is that long incubation periods of more than 48 hours to obtain the T cell
derived cytokines IL-17, IL-22 and IFNγ result in overgrowth of the fungal cells and, ultimately,
in cell lysis. Therefore, to achieve cell viability, we opted for heat-killed C. albicans. Secondly,
the immune response is enhanced when using heat-killed C. albicans instead of live C. albicans.
Heat-killing enhances the accessibility of β-glucans, whereas in live C. albicans yeast cells, β-glu-
cans are shielded from immune recognition by a mannan layer. The β-glucans, which can be
found in the inner layer of the C. albicans cell wall represent the main conserved pathogen-associ-
ated molecular patterns (PAMPs) that are recognized by one of the most important innate recep-
tors for the recognition of Candida species, known as C-type lectin receptors (CLRs) [15]. The
recognitions of β-glucans by CLRs constitutes the first step in the development of an immune
response to C. albicans. Therefore, enhanced accessibility of β-glucans results in a pronounced
immune response when using heat-killed C. albicans instead of live cells.
The transcriptome of PBMCs upon Candida stimulation was profiled by next-generation
RNA sequencing (Fig 1). A total of 312 (4 hours) and 1,476 (24 hours) protein-coding genes
were identified that showed >1.5-fold higher expression in cells stimulated with C. albicans
compared to unstimulated cells (adjusted P< 0.05) (S1 Table, S1A and S1B Fig). A total of 246
protein-coding genes were found to be more strongly induced both 4 h and 24 h after stimula-
tion (S2 Table), while 66 genes showed increased expression after 4 h only and 1,230 genes
were more strongly expressed after 24 h only.
Among the significantly differentially expressed genes, pathway enrichment analysis showed that
there is an overrepresentation of genes involved in cytokine signalling and of chemokine genes at
both 4 h and 24 h after stimulation. Pathway enrichment analysis on differentially expressed pro-
tein-coding genes confirmed previously described Candida-response pathways including cytokine
signalling (4 h: P = 1.36 x 10−12, 24 h: P = 3.19 x 10−9), Toll-like-receptor-mediated signalling [16] at
4 h (P = 0.00553), interferon signalling [17] (4 h: P = 4.90 x 10−10, 24 h: P = 1.41 x 10−5) and RIG-I/
MDA5 mediated induction of IFN-alpha/beta pathways (4 h: P = 7.55 x 10−6, 24 h: P = 0.00753) (S3
and S4 Tables) [18]. The enrichment analysis also uncovered an overrepresentation of differentially
expressed genes involved in dissolution of the fibrin clot at 4 h (P = 0.0018) and 24 h (P = 0.00422),
alternative complement activation at 4h (P = 0.0022), platelet activation, signalling and aggregation
at 24 h (P = 0.0016) and activation of C3 and C5 -a central step of complement activation- at 24h
(P = 0.00479). An even stronger effect for hemostasis (P = 6.51 x 10−6) was observed at 24h (Figs 2
Integrative genomics approach and candidaemia susceptibility pathways
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and 3). These results suggest that, along with genes involved in cytokine and interferon signalling,
genes involved in the integration of immunity and hemostasis as biological processes may also be
involved in the pathogenesis of systemic Candida infections.
Immunochip-based genetic study identifies 18 candidaemia
susceptibility loci
After identification of the transcriptome profile induced by Candida in human PBMCs, we
explored whether these pathways could be validated through genetic association data from a
clinical candidaemia cohort of 217 patients. We had previously reported three loci to be associ-
ated to Candida infection at genome-wide significance (P< 5 x 10−8) by performing a case-
control study on the Immunochip platform [9]. In addition to these three loci, during the dis-
covery stage, we identified 77 independent loci showing suggestive associations with P values
lower than 9.99 x 10−5. It is these independent loci that we have followed up in this study by
Fig 1. Transcriptome of PBMCs upon Candida stimulation. (A) Principal component analysis of RNA sequencing data obtained from eight
healthy volunteers upon stimulation of their PBMCs with C. albicans for 4 or 24 hours or unstimulated. Four distinct groups were observed
based on time-dependent exposure to C. albicans or culture medium alone using the first two principal components. Principal Component 1
(PC1, x-axis) represents 24% and PC2 (y-axis) represents 19% of total variation in the data. Green and red circles represent the stimulated
samples with heat-killed C. albicans for 4 and 24 hours respectively and purple and blue circles represent the samples incubated with RPMI for
4 and 24 hours (used as controls) respectively.
https://doi.org/10.1371/journal.pone.0180824.g001
Integrative genomics approach and candidaemia susceptibility pathways
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validating them against 146 disease-matched controls to exclude confounding effects of the
patient’s clinical background. Following screening of the disease-matched controls, associa-
tions at 18 independent loci could be successfully validated (P < 0.05; S2 Fig and Table 1).
eQTL and differential expression prioritize candidaemia causal genes
enriched for inflammation and hemostasis
To identify causal genes from these 18 susceptibility loci, three different approaches were applied.
In our first approach, we tested whether the 18 candidaemia SNPs were in linkage disequilibrium
Fig 2. Pathway enrichment analysis of the Candida-induced transcripts at 4 hours. S3 Table displays
all the signalling and biological processes as well as their enrichment p-values.
https://doi.org/10.1371/journal.pone.0180824.g002
Fig 3. Pathway enrichment analysis of the Candida-induced transcripts at 24 hours reveals a stronger
effect for hemostasis at 24 hours than 4 hours. S4 Table displays all the signalling and biological processes
as well as their enrichment p-values.
https://doi.org/10.1371/journal.pone.0180824.g003
Integrative genomics approach and candidaemia susceptibility pathways
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(LD) with variants that alter the protein-coding sequence of the gene (both synonymous and
non-synonymous). Two candidaemia-associated SNPs were identified, rs1802141 and rs12491
812, that were in strong LD with synonymous variants (S5 Table) and therefore may point to
putative causal genes. SNP rs1802141 on chromosome 16 is in strong LD (R2 = 0.82, D’ = 1) with
a synonymous variant, rs61747536, in the SPNS1 gene (Fig 4A). The SPNS1 gene, also known as
HSpin1, has been described to induce a caspase-independent autophagic cell death in cultured
Table 1. Prioritization of putative causal genes of candidaemia using an Immunochip-based association study.
Discovery cohort Candidaemia cohort
Chr position SNP P value OR P value OR Risk allele Frequency Gene(s)
1 19199400 rs6699706 1.01 x10-5 1.76 3.85 x10-2 1.58 C 0.11 ALDH4A1 a
1 113793315 rs11102637 5.86 x10-6 1.69 2.57 x10-3 1.84 A 0.15 MAGI3b
1 167833451 rs3766122 3.01 x10-5 2.02 5.03 x10-3 3.22 C 0.04 F5a, c, d
SELLa, d
SELPd
1 199183753 rs296537 1.57 x10-6 3.67 4.48 x10-2 4.74 A 0.01 IGFN1e
LAD1e
2 127943178 rs6748999 8.05 x10-6 2.21 6.23 x10-3 2.78 G 0.04 PROCc, d, e
3 50531585 rs12491812 1.67 x10-5 3.24 2.48 x10-2 10.62 T 0.01 CISHe, f
5 33987450 rs16891982 2.95 x10-5 2.14 1.48 x10-2 2.66 C 0.04 SLC45A2b
6 30078406 rs11760176 9.76 x10-5 1.99 1.20 x10-3 3.74 T 0.05 ZNRD1a
PPP1R11a
6 126875776 rs1490387 9.80 x10-5 0.68 9.15 x10-3 0.66 A 0.46 CENPWb
9 116656377 rs7022618 3.74 x10-5 1.64 3.74 x10-2 1.55 C 0.14 TNFSF15e
TNFSF8a, e
9 122664970 rs72758135 6.70 x10-5 0.45 5.77 x10-4 0.401 C 0.13 C5d
PSMD5-AS1a
STOMe
10 30763712 rs1360119 3.64 x10-7 3.62 3.42 x10-2 5.13 T 0.01 MAP3K8e
10 54523962 rs7092540 7.76 x10-5 2.50 3.01 x10-2 3.36 A 0.02 MBL2d
12 127841061 rs59665078 7.03 x10-5 1.73 1.63 x10-2 1.85 C 0.09 GLT1D1e
14 94003143 rs7149309 6.55 x10-5 2.84 3.34 x10-2 5.22 T 0.01 SERPINA1c, d, e
IFI27e
16 28909510 rs1802141 9.33 x10-7 3.06 2.26 x10-2 4.25 G 0.01 CD19d
LATc
SPNS1 f
IL27e
17 74626807 rs3848405 1.00 x10-6 3.32 1.28 x10-2 6.62 C 0.01 C1QTNF1e
LGALS3BPe
19 50102284 rs769450 6.63 x10-6 0.62 7.96 x10-4 0.57 G 0.4 TOMM40a
BCL3e
Abbreviations: Chr, chromosome; OR, odds ratio.
a Candidaemia-associated SNPs showed an eQTL effect based on publicly available eQTL datasets.
b Genes in close proximity to candidaemia-associated SNP.
c These genes are involved in the blood coagulation pathway.
d These genes are involved in the complement system.
e Differentially expressed genes in response to Candida stimulation.
f Coding variants in the CISH and SPNS1 genes were correlated with the candidaemia SNPs rs12491812 and rs1802141, respectively.
https://doi.org/10.1371/journal.pone.0180824.t001
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human cells [19]. SNP rs12491812 on chromosome 3 is in strong LD (R2 = 0.89, D’ = 1) with two
synonymous variants, rs2239753 and rs2239752, in the CISH gene (Fig 4B). The CISH locus has
been associated with major infectious diseases such as bacteraemia, tuberculosis, malaria [20],
and viral infections such as hepatitis B [21,22], suggesting shared susceptibility genes among dif-
ferent infections.
We should mention that the majority of candidaemia-associated SNPs and proxies fall
within intergenic/intronic regions, suggesting that they could have a functional potential by
affecting gene expression (S5 Table). Therefore, in our second approach, the 18 candidaemia-
associated SNPs were mapped for cis-eQTLs using publicly available eQTL datasets from
healthy blood donor samples [23–26]. Cis-eQTL mapping pinpointed 8 potential causal genes
at 6 loci (Table 1).
In our third approach, genes that were located within a 500 kb window around the 18 candi-
daemia-associated SNPs were extracted and tested as to whether they are differentially expressed
after Candida stimulation for 4 and 24 hours (S6 and S7 Tables). Within these ‘susceptibility
regions’, we found 18 and 28 genes that are significantly induced upon Candida-stimulation for 4
and 24 hours respectively in human PBMCs, raising the possibility that some of these genes could
be regulated by the candidaemia-associated SNPs in the context of Candida infection. For exam-
ple, one of the 18 candidaemia-associated SNPs, rs7149309, is located within a locus on chromo-
some 14 that harbours a cluster of ten serine protease inhibitor genes of the serpin family (Fig
4C). Serpin Family A Member 1 (SERPINA1) was significantly expressed in PBMCs in response
to Candida stimulation for 24 hours compared to the other SERPIN genes in the same locus (Fig
4D). SERPINA1 encodes human alpha-1 antitrypsin (hAAT). A protective role of AAT has been
demonstrated against different types of infectious pathogens, such as in bacterial peritonitis [27]
and pulmonary Pseudomonas aeruginosa infection in cystic fibrosis patients [28].
Together, our three approaches prioritized 31 putative candidate genes for candidae-
mia susceptibility located in 18 loci (Table 1). Intriguingly, nine out of these 31 priori-
tized genes (LAT, CD19, F5, PROC, C5, SERPINA1, SELP, SELL and SELE) are enriched in
the processes of complement and blood coagulation (Table 1, S3 Fig and S8 Table). As
expected, pathway enrichment analysis for all 31 candidaemia genes showed enrichment
for cytokine- and immune-related signalling pathways, which is in agreement with our
pathway enrichment analysis of the Candida-induced transcripts at 4 and 24 hours (Figs 2
and 3, S3 and S4 Tables). In three out of 18 loci, genes that are located in close proximity
to the top SNP were shown (Table 1), as we did not find any evidence from the above
three approaches to prioritize causal genes.
MAP3K8 modulates cytokine production in patients and in experimental
models
One of the candidaemia-associated SNPs, rs1360119, was mapped to the Mitogen-Activated
Protein Kinase Kinase 8 (MAP3K8) locus (Fig 5A). In particular, rs1360119 is an intronic
variant, suggesting that it may affect gene expression. However, rs1360119 does not show
cis-eQTL effect using publicly available eQTL datasets from healthy blood donor samples
(Table 1). That does not exclude the fact that this SNP may show an eQTL effect under con-
text-specific conditions, for instance, upon Candida stimulation. In addition, an intronic
variant can have functional effects on splicing and, therefore, we can speculate that this SNP
may affect splicing.
Of note, MAP kinases are notably attractive therapeutic targets [29]. Therefore, considering
the regulatory role of MAP3K8 protein in the production of cytokines in response to lipopoly-
saccharide [30], bacterial [31,32], and viral pathogens [33], we tested whether the rs1360119 SNP
Integrative genomics approach and candidaemia susceptibility pathways
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correlates with levels of pro-inflammatory cytokines in serum of candidaemia patients. The T
allele of the SNP rs1360119 is associated with decreased IL-6 (P = 0.018), IL-8 (P = 0.024), and
interferon (IFNγ) (P = 0.013) cytokine levels (Figs 5B–5D). Five other candidaemia-associated
SNPs showed a moderate association (P< 0.05) with circulating cytokine levels (S9 Table), sug-
gesting that some of the candidaemia-associated variants could determine susceptibility to candi-
daemia by influencing cytokine production capacity.
To test whether MAP3K8 is involved in regulating Candida-induced cytokine produc-
tion, we measured cytokine levels upon stimulation of PBMCs with C. albicans in the pres-
ence or absence of a MAP3K8 chemical inhibitor. Three different cytokines (TNFα, IL-6,
Fig 4. Prioritization of candidaemia genes enriched for blood coagulation based on eQTL and differential expression data. Regional
association plots are shown around candidaemia-associated SNPs identified in the Discovery cohort. (A) rs1802141 (P = 9.325 x 10−7) on
chromosome 16 is in strong LD with the synonymous variant rs61747536 (R2 = 0.82, D’ = 1) in the SPNS1 gene and (B) rs12491812 (P = 1.67 x
10−5) on chromosome 3 is in strong LD (R2 = 0.89, D’ = 1) with two synonymous variants, rs2239753 and rs2239752, in the CISH gene. SNPs are
plotted as the–log10 of the p-value. Local LD structure is reflected by the plotted estimated recombination rates (from HapMap) in the region around
the associated SNP (purple diamond) and its correlated proxies. The correlation of the lead SNP to other SNPs at the locus is indicated by colour.
(C) Regional association plot for rs7149309, which is located in a locus on chromosome 14, that harbors a cluster of serine protease inhibitor genes
of the serpin family, with SERPINA1 being the most likely causal gene at this locus based on our expression data upon Candida stimulation. (D)
Log2 fold change expression levels of all SERPIN genes upon Candida stimulation for 24 hours at a locus on chromosome 14 marked by the
candidaemia-associated SNP rs7149309. SERPINA1 showed a log2 fold change of ~2.6.
https://doi.org/10.1371/journal.pone.0180824.g004
Integrative genomics approach and candidaemia susceptibility pathways
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and IFNγ) known to be involved in host defence against C. albicans were measured [15].
MAP3K8 activity was blocked using three different concentrations of the MAP3K8 inhibi-
tor (10 μM, 50 μM, and 200 μM). Overall, we observed a dose-dependent reduction in all
three cytokine levels upon increasing concentration of MAP3K8 inhibitor. A significant
decrease in Candida-induced TNFα production was observed compared to the DMSO-con-
trol at 200 μM of MAP3K8 inhibitor (P = 0.03) upon 24-hour stimulation (Fig 6A). In addi-
tion, a significant decrease in IL-6 was observed upon stimulation with Candida conidia for
24 hours with 200 μM MAP3K8 inhibitor compared to DMSO (P = 0.04) (Fig 6B). We
should note that IFNγ, one of the most crucial cytokines for efficient host defence for sys-
temic candidiasis, decreased compared to DMSO after stimulation with Candida conidia
(P = 0.057) for 48 hours at 200 μM of MAP3K8 inhibitor (Fig 6C). Overall, these experi-
ments demonstrate that MAP3K8 regulates cytokine levels upon Candida infection.
Fig 5. Candidaemia-associated SNP rs1360119 affects the cytokine expression in serum from patients. (A) Regional association plot for
candidaemia-associated SNP rs1360119, which was mapped to MAP3K8 locus on chromosome 10. (B) Genotypes of candidaemia-associated
SNP rs1360119 are consistently associated with expression levels of (B) IL6 (P = 0.018), (C) IL8 (P = 0.024) and (D) IFNɣ (P = 0.013) as measured
in serum of candidaemia patients. The numbers of individuals per genotype are shown in parentheses. Cytokine levels were log transformed and P
values were obtained using Kruskal Wallis test, and 0.05 was considered statistically significant (minor allele frequency of A = 2% in Europeans from
1000 Genomes Project Phase 3, http://www.internationalgenome.org).
https://doi.org/10.1371/journal.pone.0180824.g005
Integrative genomics approach and candidaemia susceptibility pathways
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Discussion
Although Candida spp are the fourth most common cause of sepsis in the US, and the most
common cause of fungal sepsis in Europe, the difficulty of recruiting sufficient numbers of
patients has prevented the use of large GWAS studies to reveal the genetic factors involved in
the pathophysiology of Candida infections. Our study demonstrates the potential of using a
systems genomics approach to obtain novel insights into the genetic basis and host defence
mechanisms involved in relatively rare infections in which classical GWAS studies are not
applicable. By integrating transcriptomic, genetic and immunological studies, we have identi-
fied novel susceptibility genes for candidaemia and new potential therapeutic targets.
The first major group of pathways that are induced during stimulation of human PBMCs
with C. albicans are genes important for inflammation and innate immunity, cytokine and
chemokine synthesis, interferon and inflammasome signalling. This is not surprising as these
pathways have been previously shown to have a crucial role for antifungal host defence [15].
The importance of inflammation and innate immunity was also validated by genetic studies
Fig 6. MAP3K8 modulates cytokine production in PBMCs. Median expression levels of (A) TNFα (B) IL6 and (C) IFNγ in Candida-stimulated
PBMCs upon inhibition of MAP3K8 at three different concentrations (10 μM, 50 μM, and 200 μM). Candida conidia was added at a concentration of
1 x 106/ml. P values were obtained using Wilcoxon rank test (*P < 0.05). Data shown are from two independent experiments of PBMC stimulation
for 24 and 48 hours with conidia of C. albicans.
https://doi.org/10.1371/journal.pone.0180824.g006
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that confirmed that the genes determining susceptibility to candidaemia were enriched for
inflammatory genes. However, our analysis has also provided new insight in additional pro-
cesses that apparently have an important impact on candidaemia. One of these processes is
complement activation, which has been shown to modulate cytokine production induced by
Candida stimulation [34].
Hemostasis is another important biological process suggested by our study to be involved
in susceptibility to candidaemia. Hemostasis is known to be strongly activated during sepsis
and to interact with the inflammatory responses [35–38]. Strong interactions between immune
defence and hemostasis are well documented for bacterial infections, and hemostasis has been
previously associated with an increased susceptibility for bacterial sepsis [37,39,40]. Some of
the hemostasis genes that we identified as candidaemia susceptibility genes (SERPINA1, LAT
and F5) have also been shown to be important for bacterial sepsis (S4A Fig) [41]. Future stud-
ies should examine the involvement of these pathways and mechanisms in systemic Candida
infection, especially as platelets contain several anti-fungal defensins [42], indicating their
potential involvement in candidaemia. For example, an examination of protein-protein inter-
action data using the Plateletweb database found that 14 of our candidaemia susceptibility pro-
teins were found in platelets (S4B Fig).
Another novel observation of the present study is the association of SERPINA1 gene with
susceptibility to candidaemia. Mutations in this gene lead to AAT deficiency and predispose
individuals to chronic obstructive pulmonary disease and liver diseases [43,44]. Considering
the important role of AAT in modulation of inflammation, as well as the recent beneficial
effect of human AAT against bacterial infections [45], hAAT could represent a potential novel
adjuvant immunotherapy against systemic Candida infection.
MAP3K8 is known as a critical gene in innate immune responses linking pattern recogni-
tion receptors such as Toll-like receptors (TLRs) to TNF production through activation of
extracellular signal-regulated kinase [30,46]. In this study we also demonstrate that MAP3K8
plays an important role in Candida infection by modulating cytokine production. The link of
MAP3K8 with TLR-signalling suggests that the innate immune response is important in the
context of Candida infection. In particular, non-synonymous SNPs in TLR1 have previously
been associated with increased susceptibility to candidaemia, highlighting the role of TLRs in
the recognition of Candida species [47]. Furthermore, the critical role of MAP3K8 in host
immune defence has been demonstrated for other infectious pathogens including influenza
virus [33] and Listeria monocytogenes [32]. Most importantly, MAP3K8 is an important and
novel therapeutic target for inflammatory diseases [48]. A recent computational approach
using publicly available transcriptome datasets for the discovery of common immunomodula-
tors in fungal infections also pinpointed MAP3K8 and SERPINE1 in the top ten consistently
perturbed gene sets [49]. However, further functional studies are needed to shed light on the
role of these genes in host defence against Candida infection and to understand their potential
as therapeutic targets.
Several limitations also apply to this study. First, the patient cohort study is relatively small,
which limited our power to identify many of the genetic factors influencing susceptibility to
candidaemia. Second, we lack genetic validation in an independent cohort of patients. This is
because no such cohort is currently available: the cohort studied here is the largest candidae-
mia cohort currently available. In addition, a potential limitation of the present study is that
the Immunochip platform covers only 5% of the human genome, i.e. we still lack genome-
wide information. This means that further critical genetic variations for candidaemia remain
to be discovered on a genome-wide scale. Furthermore, it should be mentioned that C.albicans
is a polymorphic fungus and is encountered either as yeast or hyphal forms. The transition
between conidia and hyphae is a virulence trait of C. albicans and mutants that are locked in
Integrative genomics approach and candidaemia susceptibility pathways
PLOS ONE | https://doi.org/10.1371/journal.pone.0180824 July 20, 2017 12 / 18
the yeast form are less virulent in experimental models of disseminated candidiasis [50,51]. Dif-
ferential cytokine expression and excretion by immune cells may explain the increased invasive-
ness of hyphae. For instance, hyphae form has been shown to be unable to induce IFNγ in either
human PBMCs or murine splenic lymphocytes and conidia induced a much higher TNFα pro-
duction than hyphae did [52]. This differential cytokine expression may be attributed to struc-
tural differences in the cell wall between yeast and hyphal forms and therefore, the human innate
immune system can discriminate between yeast and hyphae [53]. In addition, the accessibility of
different pathogen associated molecular patterns (PAMPs) between hyphae and conidia of C.
albicans as well as the potential of only hyphae to activate the inflammasome can explain the
induction of immune responses that discriminate between conidia and hyphae forms [53,54].
Thus, by using only heat-killed C. albicans conidia in the present study may not represent the full
physiological conditions in humans, and further studies should address the differential effect of
both forms in PBMCs. Last, C. albicans strains may vary in pathogenicity and, therefore, may
elicit different host immune responses making it interesting to consider more clinical strains (in
addition to UC 820) for validation in the future.
To conclude, the application of an unbiased, hypothesis-free, systems integrative genomics
approach has the power to identify novel susceptibility genes for infectious diseases such as
systemic candidiasis. In this study, this approach highlighted genes in inflammation, innate
immunity and hemostasis pathways that contribute to the genetic susceptibility against candi-
daemia. We therefore believe that such integrative approaches are an important tool for future
identification of genetic susceptibility to rare infectious diseases.
Supporting information
S1 Fig. Heatmaps showing the expression of protein-coding genes, which showed>1.5-fold
higher expression, upon (A) 4 and (B) 24-hour stimulation with C. albicans in PBMCs from
healthy volunteers. RPMI medium was used as control. (adjusted P< 0.05).
(TIF)
S2 Fig. Immunochip-wide association analysis with candidaemia. Manhattan plot highlight-
ing the 18 independent loci showing suggestive association with candidaemia (P< 9.99 x
10−5) using a second set of case-matched controls. The y-axis represents the–log10P values of
122,779 SNPs. Their chromosomal positions are shown on the x axis. The dotted line repre-
sents the suggestive threshold for association (P < 9.99 X 10−5). P values were not corrected
for multiple testing when testing for association with candidaemia susceptibility at 18 indepen-
dent loci identified in the discovery stage.
(TIF)
S3 Fig. Pathway enrichment analysis based on KEGG and Reactome sources of all 31 candi-
daemia genes prioritized based on eQTL, differential expression upon Candida stimula-
tion and proximity to top SNP. Candidaemia genes showed an expected enrichment for
cytokine signalling pathways and showed a strong enrichment for complement and coagula-
tion pathways. Each node represents a separate pathway whose number of genes and P-value
are encoded as node size and node colour, respectively. Two nodes are connected by an edge if
they share members. The edge width reflects the relative overlap (corresponding to the
Fowlkes-Mallows index) between the nodes, while the edge colour encodes the number of
shared gene members. (see.tif image)
(TIF)
S4 Fig. (A) Heatmap depicts the false discovery rate (FDR) of differentially expressed genes in
sepsis as identified by Davenport E et al in their discovery and validation cohort. These genes
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were differentially expressed in response to Candida stimulation as well. (B) Proteins encoded
by 14 candidaemia susceptibility genes detected in platelets using plateletWeb (http://
plateletweb.bioapps.biozentrum.uni-wuerzburg.de/plateletweb.php). (see.tiff image)
(TIF)
S1 Table. Differentially expressed protein-coding genes in response to 4 and 24 hour-Can-
dida stimulation that showed >1.5-fold higher expression compared to RPMI medium
used as control.
(DOCX)
S2 Table. A total of 246 protein-coding genes were differentially expressed at both 4 and
24 hour-Candida stimulation, showing >1.5-fold higher expression compared to RPMI
medium used as control.
(DOCX)
S3 Table. Pathway enrichment analysis on differentially expressed protein-coding genes
that showed >1.5 higher expression compared to RPMI medium in response to 4 hour-
Candida stimulation.
(DOCX)
S4 Table. Pathway enrichment analysis on differentially expressed protein-coding genes
that showed >1.5 higher expression compared to RPMI medium in response to 24 hour-
Candida stimulation.
(DOCX)
S5 Table. Candidaemia-associated SNPs and variants with r2> = 0.8. SNPs rs12491812 and
rs1802141 were in strong linkage disequilibrium (LD) with synonymous variants located in
CISH and SNPS1 genes respectively. (source: Haploreg http://archive.broadinstitute.org/
mammals/haploreg/haploreg.php).
(DOCX)
S6 Table. Differential expression of genes that are located within a 500 kilobase (kb) win-
dow around the candidaemia-associated SNPs upon Candida stimulation at 4 hours.
Bolded genes show a log2 fold change > 1.5.
(DOCX)
S7 Table. Differential expression of genes that are located within a 500 kilobase (kb) win-
dow around the candidaemia-associated SNPs upon Candida stimulation at 24 hours.
Bolded genes show a log2 fold change > 1.5.
(DOCX)
S8 Table. All thirty-one prioritized susceptibility genes for candidaemia showed a strong
enrichment for complement and coagulation pathways along with cytokine- and immune-
related pathways based on KEGG and Reactome sources.
(DOCX)
S9 Table. Five additional candidaemia SNPs showed a moderate association with circulat-
ing cytokine levels as measured in serum from candidaemia patients. Cytokine levels were
log transformed and statistical significance was tested with Kruskal Wallis test.
(DOCX)
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